Prostate-specific antigen, clinical use and staging: an overview
- 1 March 1997
- journal article
- review article
- Published by Wiley in British Journal of Urology
- Vol. 79 (S1) , 53-60
- https://doi.org/10.1111/j.1464-410x.1997.tb00802.x
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Physiological Variation of Serum Prostate Specific Antigen in the 4.0 to 10.0 ng./ml. Range in Male VolunteersJournal of Urology, 1996
- Complex Formation Between PSA Isoenzymes and Protease InhibitorsJournal of Urology, 1996
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volumeCancer, 1993
- The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasiaThe Prostate, 1993
- Prostate‐specific antigen: Establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrationsThe Prostate, 1992
- Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitorsEuropean Journal of Biochemistry, 1990
- Prostate‐specific antigen and prostate gland volume: Correlation and clinical applicationJournal of Clinical Laboratory Analysis, 1990
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987